Cancer Letters
Volume 210, Issue 1 , Pages 7-15, 8 July 2004

Limited tumor growth (HT29) in vivo under RO205-2349 is due to increased apoptosis and reduced cell volume but not to decreased proliferation rate

This publication is dedicated to Prof. H. Marquardt on the occasion of his retirement

  • Marcus Katoh

      Affiliations

    • Institute for Anatomy II: Experimental Morphology, University Hospital Hamburg-Eppendorf, Martinistrasse 52, Hamburg D-20246, Germany
    • ,
  • Susanne Feldhaus

      Affiliations

    • Institute for Anatomy II: Experimental Morphology, University Hospital Hamburg-Eppendorf, Martinistrasse 52, Hamburg D-20246, Germany
    • ,
  • Tobias Schnitzer

      Affiliations

    • Roche Diagnostics GmbH, Werk Penzberg, Nonnenwald 2, D-82372 Penzberg, Germany
    • ,
  • Sabine Bauer

      Affiliations

    • Roche Diagnostics GmbH, Werk Penzberg, Nonnenwald 2, D-82372 Penzberg, Germany
    • ,
  • Udo Schumacher

      Affiliations

    • Institute for Anatomy II: Experimental Morphology, University Hospital Hamburg-Eppendorf, Martinistrasse 52, Hamburg D-20246, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49-40-42803-3586; fax: +49-40-42803-5427

Received 24 January 2003; received in revised form 9 January 2004; accepted 12 January 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3835(04)00055-2

doi:10.1016/j.canlet.2004.01.010

Cancer Letters
Volume 210, Issue 1 , Pages 7-15, 8 July 2004

Article Tools

* Image Usage & Resolution